View of Helmet Continuous Positive Airways Pressure (CPAP) treatment in a Non-Small Cell Lung Cancer (NSCLC) patient with severe hypoxemic respiratory failure due to gemcitabine therapy

Return to Article Details Helmet Continuous Positive Airways Pressure (CPAP) treatment in a Non-Small Cell Lung Cancer (NSCLC) patient with severe hypoxemic respiratory failure due to gemcitabine therapy Download Download PDF